Sign in to view Jennifer’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Sign in to view Jennifer’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
San Francisco Bay Area
Sign in to view Jennifer’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
3K followers
500+ connections
Sign in to view Jennifer’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View mutual connections with Jennifer
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View mutual connections with Jennifer
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Sign in to view Jennifer’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Websites
- Personal Website
-
http://www.jenniferjones.com
- Personal Website
-
http://www.marketingvoices.com
About
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
Articles by Jennifer
-
Social Media IS 21st Century Marketing
Social Media IS 21st Century Marketing
I recently wrote this article for a publication called Venture Capital Journal. It was written for this professional…
5
1 Comment
Activity
3K followers
-
Jennifer Jones reposted thisJennifer Jones reposted thisBig news from our team at Qualified Health: we just closed an oversubscribed $125M Series B led by NEA and Transformation Capital 🎉 And we're hiring! Nurse leaders, product leaders, applied AI engineers — links in the comments. Here's what we've learned building this: The health systems seeing real results aren't treating AI like an add-on. They're making a bigger bet, rethinking the whole way they work. And when they do, the results are real: • >$30M in run-rate impact identified and realized in under six months • 1,000s of patients identified for critical, missing evidence-based care, now receiving it • Clinical registries and patient safety workflows that used to take days, now running in minutes I’m grateful for the 20+ leading health systems that have taken a bold bet on this vision including Mercy, Emory, University of Rochester, Jefferson, and the entire University of Texas System. Why join us right now? We were just named a Fierce 15 company. We were the first US healthcare organization to collaborate with Anthropic on a frontier AI deployment. We've grown revenue 10x in the last year. And we're partnered with health systems representing more than 7% of US patients. If you want to do the most meaningful work of your career in healthcare AI, message me directly. 👇
-
Jennifer Jones reposted thisJennifer Jones reposted thisEarth from 70,000 feet. No borders. No noise. Just a thin blue line holding everything we know. You see how little separates us from the rest of it. How fragile that layer is. This is home. The only one we’ve ever had. Happy Earth Day. #U-2
-
Jennifer Jones reposted thisGreat press briefing today at LogiPharma. What an incredible day with the supply chain execs serving the world’s patients. #supplychain #pharmasupplychain #medtechsupplychain #riskinmotionJennifer Jones reposted thisStanding room only at our LogiPharma press briefing this morning – huge energy around how we’re helping Pharma, MedTech, and beyond tackle risks across their supply chain through predicted behavior. Allison Griffin Fowler, Dominik Schmidt, and Dennis Groseclose chatted with the press about what TransVoyant is doing to help our customers reduce logistics costs by 10-25%, save 4M temperature controlled doses, and - most importantly- serve patients on time. If you’re here at LogiPharma swing by Booth #134 today for a 5-minute live demo and a deeper dive into our mission. Are you on-site? Send me a DM and we’ll find you a slot. Rose Belizor Elinor E. Anastasiia Liadyk
-
Jennifer Jones reposted thisAttention sports fans: Amazing oppty! Lmk if you might want an introJennifer Jones reposted thisLooking to hire a Sr. Director of Comms and PR at X Games. Someone scrappy, unafraid to move fast, knows how to break news (local and national), control a narrative, and turn moments into momentum. This role owns all internal and external comms. However, you can’t apply for yourself, you have to recommend someone in the comments below. Who should we hire? 🚀 BTW last time I asked, we ended up hiring one of your recommendations: cc Sami Seiden
-
Jennifer Jones reposted thisJennifer Jones reposted thisThank you to Global Corporate Venturing and Ian Goldstein of Fenwick & West https://lnkd.in/e3inGiQH for the opportunity to share my thoughts at the annual GCV Summit https://lnkd.in/eWkmxHHf related to a question that’s becoming more pressing for CVCs: what does real strategic value look like when M&A isn’t the end game? What’s changing is clear. CVC is moving beyond transactions toward integration—beyond optionality toward execution. It’s not enough to invest in great companies; the real test is whether those partnerships take hold inside the enterprise and drive measurable impact. A few key takeaways: • Strategic value must show up in operations—not just in strategy decks • The shift from “pushing” startups to “pulling” solutions from real enterprise needs is critical • Structured pilots + committed teams = repeatable partnerships and scale • Collaboration across corporates is becoming a competitive advantage, not a compromise. I appreciate James Mawson https://lnkd.in/erKbppEP and Christina Riboldi https://lnkd.in/e2T6sDbF for the invitation to speak. #CorporateVentureCapital #GlobalCorporateVenturing #GCVSummit
-
Jennifer Jones reposted thisJennifer Jones reposted thisI am honored to be named a 2026 INNOVATE100 honoree. This recognition reflects the work of a team that shows up every day to build, challenge assumptions, and push innovation forward where it actually matters. I’m grateful to the team at Merck Global Health Innovation Fund, for their partnership, perspective, and persistence behind everything we do. And congratulations to the full INNOVATE100 class—I’m looking forward to celebrating together on May 13 at the New Brunswick PAC. #innovate100 #innovation #leadership #collaboration @Jersey Tech + Innovation #JamesBarood
-
Jennifer Jones reposted thisJennifer Jones reposted this🏁 HLTH USA 2026 registration is officially OPEN. Healthcare has hit a point of no return. AI is no longer experimental. Patients aren’t waiting. And the breakthroughs? They’re happening now, in real systems, with real impact. The age of intelligent healthcare is here, and the pace of change isn’t slowing down. Join us November 15–18 at The Venetian in Las Vegas, where the health ecosystem comes together to challenge assumptions, spark partnerships, and move the industry forward. This year, we’ve introduced more flexible, bespoke pricing options to make it easier to be part of the conversation. Register now for #HLTHUSA while pricing is at its lowest. https://lnkd.in/e_7Hqdsw
-
Jennifer Jones reposted thisJennifer Jones reposted thisFebruary saw #exits for corporate-backed #startups reaching their highest point in the last two years, according to GCV data. This was largely due to the merger of generative #AI developer xAI into SpaceX at a $250bn valuation. The merger was also part of the 25 #IT exits recorded last month, making it the biggest month for #IT exits in at least two years. Link in comments for the full analysis. #CVC #corporate #genai #fintech
-
Jennifer Jones reposted thisCongratulations to the UNP team. Excited to be part of the journey.Jennifer Jones reposted thisExcited to share that we've raised $45 million in Series B financing to advance a new class of medicines built on synthetic macrocyclic peptides. The round was led by The Venture Collective (TVC), with participation from argenx, Droia Ventures, Merck Global Health Innovation Fund, ARTIS, and First Spark Ventures. Macrocyclic peptides represent an emerging therapeutic modality that combines the precision of biologics with the delivery advantages of small molecules, opening the possibility of targeting complex targets that have historically been considered “undruggable.” with traditional small molecule approaches and providing oral solutions for targets only addressable with injectables. This financing will support the continued development of Unnatural Products’ discovery platform and advance its pipeline of macrocyclic peptide therapeutics across cardiometabolic, inflammatory, and immunological diseases. The announcement follows the company’s recently disclosed Novartis collaboration, which includes up to $100M upfront and and pre-IND milestones as well as $1.7B in potential milestones and royalties to develop macrocyclic peptide therapeutics for cardiovascular targets. Congratulations to our team on this milestone, and thanks to our investors and partners for their support! Read the release: https://lnkd.in/gfrjbG6G
-
Jennifer Jones liked thisJennifer Jones liked thisThank you to everyone who attended the panel, "Beyond the Buzz: What's Next for Generative AI in Health and Care" this week at the 14th Annual DHIS East in Boston, MA, hosted by our very own Michelle Snyder! This panel featured a prudent conversation around the true value that generative AI can bring to the greater healthcare landscape, and we're grateful to have been able to participate in the event. Special thanks to all of the other panelists, including Julia Hu (Lark Health), Mark Michalski (Deerfield Management + Ascertain), Allison (MacRae) Santoro (Biogen), Jared Kesselheim (Transformation Capital), and Carl Bradford Byers 🚑 (F-Prime) for the insightful and thought-provoking discussion! Additional thanks to Jason Green and Benjamin Lakin, PhD from Cambridge Innovation Institute for putting together such a wonderful event, along with Ian Chiang (Flare Capital Partners), Caitlin Donovan (General Catalyst), and Gil Addo (Waterline Ventures) from the advisory board for making this panel possible. Until next time—we love you, Boston! ❤️ 📸: Cambridge VIP: Venture, Innovation & Partnering #DHIS26 #DHIS2026 #CambridgeVIP #DigitalHealth #MedTech
-
Jennifer Jones liked thisJennifer Jones liked this10 years of CrossFit. Here's what a decade of consistency taught me about work. A decade ago: overweight, out of shape, couldn't run a mile or do a single pull-up. I had medical issues, the bio metrics were going the wrong way. Today: 3 to 5 sessions a week, weightlifting on the side, and 12+ obstacle course races completed (photo of a Spartan race, yes real fire I got the trifecta). Added muscle, lost fat, I fixed those medical issues, the bio metrics are going the right way, and I'm holding. What I learned goes well beyond the gym. Consistency beats intensity. Showing up three times a week for ten years compounds in ways one fad workout will do The discipline transfers. The same muscle that gets me to a 5 AM class is the one that powers through the events, speeches, meetings, and funding cycles Stamina is the long game. My career mission requires endurance, and I've spent a decade training for it, often without realizing it. I highly recommend CrossFit, very different workouts different every day, excellent coaching, and all the equipment is right in the gym, one hour in and out. And you'll make friends, motivation. Here's to the next ten.
-
Jennifer Jones liked thisFor years, I’ve driven the 101 between San Francisco and Palo Alto - in the heart of Silicon Valley - and admired the billboards of the hottest tech companies. It’s a milestone to be sharing our message in this corridor of the greats. 💜 #TeamMedableJennifer Jones liked thisPassing through South San Francisco, this hits a little different. 💯 The mission is what matters, and ours is getting therapies to patients faster. Drop a comment if you've seen it on your commute! 🚗
-
Jennifer Jones liked thisJennifer Jones liked thisDelighted to congratulate Jonathan Ng and the Iterative Health team on their $77M Series C, led by Intrepid Growth Partners and GV (Google Ventures). Breyer Capital has been proud to back Iterative since the Series A. AI is reshaping every layer of medicine, and clinical research is among the highest-leverage places to apply it. Iterative Health has built the rare combination of technology and network that turns AI from promise into measurable acceleration for patients waiting on tomorrow's therapies. Congratulations to Jonathan and the full team. Morgan Cheatham, MD Bret Bostwick, MD, FAAP, FACMG Daniel Breyer Ted Breyer
-
Jennifer Jones liked thisJennifer Jones liked thisSave the Date: GCV Asia 2026 🗓️ November 9–11, 2026 📍 Tokyo, Japan Get ready for GCV Asia - bringing together corporate venture capital and open innovation leaders from across APAC. Discover a rapidly maturing ecosystem, where corporate-backed deals account for 67.4% of market value and industry powerhouses drive 60% of Japan’s venture funding. Expect expert-led sessions, curated 1-to-1 meetings, and unmatched access to the region’s key players. 🌏 20+ countries represented 👥 150+ delegates annually 🎤 ~60 speakers shaping the future of innovation #GCVAsia #CVC #Innovation #VentureCapital #APAC #Tokyo www.gcvasia.com
-
Jennifer Jones liked thisJennifer Jones liked thisApril is Autism Awareness Month, but our family is proud of our son, Milan, who has autism every day. Milan graduated high school with honors last year and for the next four years is taking part in the Adult Transition Program. This is an amazing program that prepares students with special needs ready for entering society as responsible adults. He is competing in special Olympics, working part time at Old Navy, learning to cook and clean and having fun doing all of that. He bought the family pizza with his first paycheck. We are so proud of him!
-
Jennifer Jones liked thisJennifer Jones liked thisReddit reported its latest quarterly earnings that beat on the top and bottom, and shares jumped over 9% in extended trading. CEO Steve Huffman said during an earnings call that Reddit now has seven consecutive quarters in which revenue growth was over 60% and that it's seeing "record cash flow of more than $300 million." The company's core business has bloomed all while it's been spending peanuts on capital expenditures (ie, data center and computing infrastructure), he said. "At the same time, our capital expenditures remains low at just $1 million, underscoring the advantage of Reddit's capital-light model," Huffman said. "When you look across the more than 300 publicly traded tech companies, there's only one that combines this type of growth, profitability and efficiency, and that's Reddit." Huffman's comments on Reddit's light capital expenditure spending come a day after the much larger online advertising giants Meta and Alphabet reported their latest quarterly earnings. Both Meta and Alphabet are increasing their capex spending: Alphabet provided 2026 capex guidance of $180 billion to $190 billion, up from its previous estimate of $175 billion to $185 billion. Meta said that its capex guidance for the year will come in between $125 billion and $145 billion, up from a prior range of $115 billion to $135 billion. Read more below from CNBC: https://lnkd.in/earhrZGYReddit reports 69% jump in revenue, topping analyst estimatesReddit reports 69% jump in revenue, topping analyst estimates
-
Jennifer Jones liked thisJennifer Jones liked thisGreat time at the Foundation Capital annual general meeting. Big shoutout to Foundation Capital, top tier firm consistently backing ambitious, category defining companies and supporting founders through the journey. Grateful to have co-invested alongside them in Cerebras and Tennr. Appreciated the conversations and insights. Great connecting with Steve Vassallo and Joanne Chen, one of the best investors in venture world.
-
Jennifer Jones liked thisJennifer Jones liked thisListen Here: https://lnkd.in/gBT46u4x In this episode, Dr. Kedar Mate, co-Founder and Chief Medical Officer Qualified Health, speaks with Nabile Safdar, Chief AI Officer, Emory Healthcare and Emory University, about practical strategies for AI adoption, from building trust with clinicians to scaling deployments effectively. They explore how leadership, consistent change management, and a strong organizational culture are essential to turning AI innovation into measurable outcomes. This episode is sponsored by Qualified Health. For more information about Becker's Healthcare, please contact Jessica Cole or Scott Becker. #podcast #healthcare #leadership #innovationinhealthcare
Experience & Education
-
Jennifer Jones & Partners
*******
-
******** ******* *******
********* *******
-
***** ******* ***
********* **** ********* ******* *******
-
******** **********
******** ********* ********** ******* ******** undefined
-
-
********** ** ******** ** *******
********** ****** ******** *** *********
View Jennifer’s full experience
See their title, tenure and more.
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Publications
Courses
-
Finance, Accounting
-
Projects
-
M&A International Global 2013 and 2014 Best Communications Firm in Venture Capital and Private Equity
Jennifer Jones & Partners won the M&A International Global 2013 Award for the best communications firm in venture capital, and private equity industries worldwide. JJ&P was selected from a vote of venture capital and private equity members of more than 185,000 people worldwide.
-
DealMakers Magazine Best Communications Firm in Venture Capital and Private Equity
-
Awarded international award for best marketing communications firm for venture capital and private equity for four years in a row: 2011-2014.
Languages
-
English
-
Recommendations received
10 people have recommended Jennifer
Join now to viewView Jennifer’s full profile
-
See who you know in common
-
Get introduced
-
Contact Jennifer directly
Other similar profiles
Explore more posts
-
Katie Griff
Red Cell Partners • 4K followers
AI doesn’t have to be complicated, but it does need to work for society’s most critical industries. From healthcare to defense, current solutions lack the deep knowledge to solve organizations’ highly complex use cases. Enter Trase, led by Grant Verstandig, Baskar Sridharan, and Joe Laws. Trase is combining industry-leading tech with deep domain expertise to deliver autonomous, end-to-end, turnkey agents designed to drive real ROI across highly regulated sectors, with compliance, trust, and security guiding their every move. Today, Trase launched out of stealth with $10.5 million in pre-seed funding from Red Cell Partners and VIPC | Virginia Innovation Partnership Corporation. Learn how we’re enabling last-mile AI adoption across various enterprises, starting with healthcare, energy, and national security: https://lnkd.in/egJYdNKz
11
1 Comment -
Aly Madhavji
Blockchain Founders Fund • 30K followers
Institutions don’t fail all at once. They fail when design can’t keep up with change. In Davos this week, I’ll be joining the inaugural gathering of the Institutional Research Network, a new initiative convened by The Digital Economist. The focus is not another set of conversations but the patient work of connecting research, markets, and governance so ideas can take institutional form and hold under real-world pressure. Some initiatives are about visibility. This one is about durability. #Davos2026 #InstitutionalDesign #IRN #TheDigitalEconomist
18
1 Comment -
Sean Smith
Search Fund Ventures • 8K followers
I spoke with Christien Louviere of BDE Capital about his journey from a $330mm exit to becoming an independent sponsor. Christien shared excellent insights for folks looking to partner with business owners, rather than buy sellers out completely. Below are a few of the topics we covered: - Why he moved from “zero-to-one” startups to a buy-then-build strategy - How Christien's background shaped a focus on growth vs. cost-cutting - Why 20–40% rolled equity is central to his deal structures—and how it builds trust with sellers - Using scenario analysis with AI tools to evaluate management teams and uncover hidden key-person risks - How to identify when a $3–5M EBITDA company truly has a middle management layer—or is still founder-reliant For anyone investing in or buying small businesses, Christien’s approach provides a fresh lens on growth, alignment, and deal structuring. 🎥 Watch the full interview here → https://lnkd.in/ekfkaiej 🎧 Listen on Spotify: https://lnkd.in/e86Agx6V
33
8 Comments -
Paul Perrett
Firmable • 3K followers
Big milestone for Firmable. We’ve raised $14m Series A led by Airtree. Sales has moved through a few big waves: intuition-led, CRM-led, data-led. We’re now entering the next one – intelligence-led sales. The opportunity isn’t just better data. It’s turning that data into clear direction and action, without adding more work for sales teams. That’s what we’re building at Firmable: a foundation of trusted external data, layered with intelligence that helps sellers know who to focus on and when. Led by Airtree, this round supports our expansion across Asia and into the US – and accelerates the build-out of AI agents that take the admin work off sales teams so they can focus on what they do best. Proud of the team, grateful to our customers and investors. We’re just getting started. Read the exclusive in the AFR. https://lnkd.in/gr66uknb Leigh Jasper | Tara Salmon | Karthik Venkatasubramanian| Chester Thompson| Chath Widanapathirana
147
20 Comments -
Gordon Ritter
Emergence Capital • 6K followers
Growth at all costs is out. Strategic expansion is in. One stat from our new report that says it all: By $100M ARR, 67% of growth comes from expansion, not net-new customers. We’re seeing a mindset shift among top-performing founders. They’re prioritizing customer success early, building in product-led growth loops, and measuring how they grow, not just how fast. Full analysis and benchmarks here: https://lnkd.in/gZruurYs #AI #SaaS #CustomerSuccess #BeyondBenchmarks
107
5 Comments -
Michael Sidgmore
Broadhaven Capital Partners • 26K followers
What does the "new era" of private equity look like? This week at PEI NEXUS, Bain & Company's Chairman of Global Private Equity Practice Hugh MacArthur recapped the firm's latest Global Private Equity Report. Hugh noted that firms will need to focus on what they do well in a “new era” for private equity. These sentiments echoed much of what Private Wealth Forum speakers, including Arax Investment Partners Founder and CEO Haig Ariyan, Laird Norton Wetherby CIO Ron Albahary, CFA, Ardian Managing Director, US Private Wealth Solutions Ava Mallin, and Citi Wealth Head of Private Equity and Real Estate Jeffrey Locke, shared on stage at PEI. This week's AGM Alts Weekly dives into what a "new era" in private equity might look like, connecting dots and data points from Bain & Company and McKinsey & Company's 2026 reports on the state of the private equity industry. Some key themes defined the takeaways from both reports: ➡️ Returns will not be a dime a dozen: Bain's punchline? "12 is the new 5." ➡️ Megadeals, big questions: 2025 witnessed an increase in global buyout deal value. However, just 13 deals of $10B or more contributed 69% of the growth in 2025, accounting for $274B of the global gain. ➡️ A K-shaped industry: Private equity appears to turning into a K-shaped industry, with “a subset of elite funds [being] on the upswing while everyone else muddles through.” ➡️ No fun in fundraising: McKinsey noted that core, closed-end fundraising has “become more competitive, selective, and time consuming.” ➡️ Continuation nation: There’s been a marked rise in continuation vehicle activity, but only represents less than 10% of exit value. ➡️ Mid-sized deals not so mid: Megadeal activity grabbed the headlines. But deal sizes $1-5B deals grew 29%. Growth in the $1-5B deal size segment could be encouraging for specialist buyout funds. There are some key questions for allocators to grapple with as they think about what private equity might look like in the future. 1️⃣ Do allocators believe public markets will continue to outperform private markets? 2️⃣ Will fundraising bounce back? 3️⃣ Can firms kick value creation into motion? 4️⃣ Are both GPs and LPs ready to handle how investors might look to exit evergreen vehicles? 5️⃣ For LPs, are they finding managers that have an edge? Read on for more👇 This week's Alt Goes Mainstream's AGM Alts Weekly, brought to you by DealsPlus, covers: 🗂️ AGM Index, an index that tracks the leading publicly traded alternative asset managers. 💻 Who is hiring: Senior-level positions from companies Blackstone, KKR, Apollo Global Management, Inc., Ares Management, EQT Group, Blue Owl Capital, Franklin Templeton, Fortress Investment Group, iCapital, Goldman Sachs, Ultimus Fund Solutions, Krilogy, MSCI Inc. Subscribe👇 to see the latest trends & navigate this rapidly changing landscape as alts go mainstream. https://lnkd.in/eRKN25jy
26
3 Comments -
Anjli Jain
ElevenX Capital • 35K followers
**Leveraging Community Feedback for Elevated Engagement** X's initiative to use Community Notes for identifying top posts underscores the power of user feedback in shaping content engagement. As venture capitalists, understanding community sentiment can help us guide portfolio companies towards creating more relevant, impactful content. At ElevenX Capital, we believe that aligning product offerings with user preferences is crucial for sustained growth. How can we, as investors, harness community insights to support startups effectively? #investing #innovation #venturecapital #entrepreneurship
2
-
Carmichael Roberts
Breakthrough Energy Ventures • 9K followers
Company building in energy is shaped by early decisions that compound over time—how capital is structured, how technical risk is absorbed, and how teams prepare for scale well before it arrives. Much of my work with founders centers on navigating those choices as deep science becomes real businesses. The details differ across power, materials, and industrial systems, but the challenge is consistent: building companies that can operate, adapt, and grow over long horizons. You can see that work taking shape across the Breakthrough Energy portfolio. https://lnkd.in/eXd72trE
88
4 Comments -
Amanda Cybul
Merge • 19K followers
Agency M&A is on fire. 🔥 At Merge, we’re seeing more activity than ever, especially for agencies valued under $20M. Buyers are coming from every direction: PE-backed platforms, strategic acquirers, and first-time entrepreneurial buyers. It’s simple economics: demand is outpacing supply. Here’s what’s happening in the market 👇 1️⃣ The sub-$20M sweet spot This is where the action is, and it’s all about the size of the buyer pool. At this level, agencies attract interest from every buyer type: strategic acquirers, PE groups, entrepreneurs, and even financial or silent investors. The moment you move above $20M, that pool narrows fast, leaving mostly private equity. Under $20M, the field is wide open, and that competition is driving pricing and velocity. 2️⃣ The rise of the entrepreneurial buyer A few years ago, agency M&A was dominated by PE firms and large strategics. Not anymore. Now everyone wants to be an entrepreneur, and agencies have become one of the most accessible, profitable entry points. Today’s market is full of independent entrepreneurs, many using SBA financing to buy their first agency. This new wave of buyers is keeping demand hot and competition fierce. 3️⃣ The AI effect (and reality check) Last year, everyone was nervous about AI. Now buyers are confident. AI is reshaping (not replacing) the landscape. Brands still need to drive growth, visibility, and revenue. The agencies leveraging AI intelligently, not fearing it, are the ones commanding premium multiples. 4️⃣ Story clarity wins every time If a buyer can instantly understand what you do and who you serve, you’re already ahead. The agencies getting the most attention have a crystal-clear story, whether that’s a defined vertical or a sharp capability focus. You might alienate some buyers, but for the right one, you’re a perfect fit. ❤️ 5️⃣ Down year? Still sellable. Revenue dips aren’t deal killers. Buyers care about normalized profitability and strategic fit. If you’ve right-sized your team and tightened margins, we can adjust the expense base in modeling, and buyers will still line up if the fundamentals are strong. What we’re seeing on multiples 💰 • Agencies under $2M in adjusted EBITDA: 3–6× • Agencies over $2M: 5–8× Where you fall within that range depends on what you do, how well you do it, and the risks buyers perceive about your agency. Typical structure: 💵 Majority cash at close 📈 Performance-based earnouts 🤝 Rollover equity when there’s a platform angle Bottom line: The agency M&A market is booming. Smart founders are taking advantage of it. The “wait and see” crowd is missing the moment. 💬 Send me a message to talk about what your agency is worth in today’s market!
662
104 Comments -
KEVIN RAPER
The Fulcrum; Work • 3K followers
Got to have a great call today with Jonathan Hakakian. Jonathan is the co-founder and Managing Partner of SoundBoard Venture Fund - an early-stage fund investing primarily outside major coastal hubs. They've built a portfolio of 40+ companies across the US in underserved geo., with notable exits including Jump (acquired by Uber). We didn't talk enough about what he's doing - because we got wonderfully sidetracked. We talked about The Fulcrum; Work. About Iranian food. About food as both a love language and a window into culture. About learning and the 2nd part of life journey... And then we got into something I care deeply about: how to fund the companies that aren't "VC backable" by traditional standards but are absolutely worth backing. Not every great business fits the venture mold. Jonathan gets that. SoundBoard is built on character over skill, close founder relationships, and creative structures that meet founders where they are. That's my kind of investor. Heidi Knoblauch you should be in this conversation. I think you'd connect on much of this part! I'm excited by Jonathan's approach. His thoughtfulness. The way he shows up for founders outside the usual corridors. Ive learned quite a bit from him. Very much looking forward to our next call - and to his next fund. This is how ecosystems get built. One good conversation at a time.
19
4 Comments -
Daniel Dart
Rock Yard Ventures • 10K followers
🚨NEW EPISODE: Recorded live at FUTURE TITANS 2026 - Jeff Perry of Carta sat down with the iconic Seth Levine, co-founder of Foundry. Seth has been in venture for 25 years, built Foundry from scratch as an emerging manager himself, and has backed about 50 emerging manager funds through his fund of funds. He has genuinely seen every side of this table. They went deep on building Foundry, why VCs are in the influence business, not the decision business, and why the concentration problem in venture is not only bad for LPs, but also for the innovation ecosystem overall. And why Seth's new book, Capital Evolution, is so important for the future of America. 🎧 Links to listen... Apple: https://lnkd.in/ehQUQ2EM Spotify: https://lnkd.in/eU4FExpg
19
1 Comment -
Mary Glaz
Mission Space • 9K followers
Lower launch costs, dual-use tech validated by government demand, and faster exit timelines mean generalist VCs now have a real entry point. With $4.5B invested across 48 companies this year, venture funding in space is scaling beyond rockets into applications, infrastructure, and defense. Space is colliding with climate tech, AI, and resource plays. FireSat’s wildfire monitoring constellation, Planet Labs’ collaboration with Anthropic, and Interlune’s helium-3 vision show that the next wave of space investment is not about launch but about applications with terrestrial impact. Historically, space investments took decades to return capital. Now, IPOs like Voyager and Karman Space & Defense, plus the prospect of strategic acquisitions, make the sector investable within standard VC fund timelines. This is critical for bringing more generalist investors into the market. Let's build!
9
1 Comment -
Zorian Rotenberg
Harvard Business School • 17K followers
PE Boards as a Differentiator (for portfolio companies) If you heard the Shore Capital episode on "Invest Like the Best" podcast - there is one interesting insight for PE firms. Board Composition: - each board is built like a sports team with complementary skills - operators, VOC, adjacent sector experts This is a true differentiator because most boards are not intentionally built like a high-performing sports team. Also, there is one particular operator profile every B2B portfolio company should have on its board: a GTM expert (i.e. former CRO). All B2B portfolio company board discussions consistently focus on sales and revenue growth, making this one of the most impactful board roles. All top decile PE firms have a GTM expert in-house as an Operating Partner specializing in GTM who joins board meetings to spot upside opportunities and help see around corners and mitigate risks. P.S. Relating to the GTM, sales, and growth side, there’s a well-known story about Michael Ovitz serving on the board of Gulfstream Aerospace while it was owned by the PE firm Forstmann Little & Co. Michael Ovitz said that he and other board members, like Colin Powell, were so focused on GTM they even got on the phone to help sell jets. It was an entirely GTM-focused board which helped turn around Gulfstream. #pe #privateequity
52
1 Comment -
Earnest Sweat
Stresswood • 17K followers
Two weeks ago on Swimming with Allocators, we sat down with David Clark, CIO at VenCap, to talk about what decades of venture data can teach allocators. One takeaway that stood out: discounts don’t matter as much as people think in venture secondaries. Because venture is such a power-law asset class, outcomes are driven by exposure to a few massive winners. Whether a stake is bought at a small discount, or even a premium, often matters far less than the quality of the underlying company and its upside. Great conversation on venture returns, manager selection, and the nuances of how allocators should think about secondary investments. 👇 Link in the comments.
26
2 Comments -
Clay Fisher
Spark Capital • 2K followers
Much of the money and time in healthcare happens past the point of diagnosis. The money: $200B of spend on specialty drugs. The time: putting patients on therapies requires clinical judgment, and navigating a labyrinth of paperwork and people. The result is a byzantine status quo where patients get life saving therapies denied or delayed, and hospital systems capture only $80B of the $200B of drug spend that they originate. Latent’s groundbreaking clinical AI is a portal into the future. Patients get therapies quickly with personalized care, and hospitals transform their bottom line. As a result, Latent has seen extraordinary traction, working with over 50% of the top 20 U.S. health systems in under a year. Latent is one of the biggest and most strategic opportunities in healthcare, sitting in between providers, payors, patients, and pharma. Spark Capital is delighted to support Rishabh Jain and Sriram Somasundaram and this consequential company and to work with Sarah Guo and Michael Dixon.
73
-
Henry D. Wolfe
DaVega & Wolfe Industries… • 1K followers
Public Co. Boards - Think And Function Like A Raider Or Activist "There are numerous providers that work with public companies to develop defenses against shareholder activism. Yet the most foolproof way to avoid corporate raiders or activist investors is to position the company for value maximization and go about creating the same. It is axiomatic that raiders and activists do not pursue high performance companies." #corporategovernance #governance #boardsofdirectors #investors #institutionalinvestors #shareholderactivism #shareholdervalue https://lnkd.in/g3vvw6SM
8
1 Comment -
Avi Savar
Velocity Road • 8K followers
Why do private equity sponsors and CFOs see AI so differently? 98% of PE sponsors demand immediate AI adoption while 68% of CFOs admit they don't know where to begin. This disconnect reflects a broader truth about innovation—vision without executional guidance creates paralysis. In my experience, the CFOs asking 'where do I start?' often end up ahead of those with grand strategies but no practical roadmap. The shadow AI economy shows us the answer: start with what employees are already using successfully, then scale with proper governance... The question isn't whether AI transformation will happen—it's whether leadership will learn from the 90% of workers who've already figured it out. Read more in the latest Velocity Meter newsletter:
2
-
Cory Weinberg
The Information • 4K followers
Figma's IPO is likely to deliver more wealth to more firms than any IPO since 2021. Three takeaways: 1. It's a rich-get-richer moment. One unreported detail is that Figma's 2013 seed round included a ~$1.5M check from ICONIQ, which then an up-and-coming tech investment manager with money from Sheryl Sandberg and other bigwigs. That stake is now worth over a half-billion. 2. The biggest profits are going to firms that took the biggest leap of faith in Dylan Field. Three firms that invested before Figma generated any or much revenue—Index Ventures, Greylock Partners, Kleiner Perkins—stand to profit a combined $4B, at the high end of the range. 3. There are some what-could-have-beens. Accel didn't look at Figma's Series B because it already was in a competitor (who is now out of business). Foundation Capital approved an investment offer in the same round that Kleiner outbid handily. And big Figma investors like Greylock Partners, Kleiner Perkins and Sequoia could have made even more if they got conviction earlier. (All three win big, but passed on earlier rounds.)
33
2 Comments
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content